课题基金 / 基金详情

Immuno-gene therapy for non-small lecclung cancer using innate immunity by NKG2D and its ligand.

Immuno-gene therapy for non-small lecclung cancer using innate immunity by NKG2D and its ligand.
利用 NKG2D 及其配体的先天免疫对非小细胞肺癌进行免疫基因治疗。
批准号:
13670588
负责人:
SAIJO Yasuo
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SAIJO Yasuo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
NKG2D and its ligand, play a crucial role for innate immunity against to tumor. We developed adenoviral vector coding murine NKG2D ligand RAE-1 (Ad.CMV.RAE-1). When mouse colon cancer cells C26 were infected with Ad.CMV.RAE-1, these cells developed slightly slower than control C26 cells. Because RAE-1 showed very limited effects, we also constructed adenoviral vector expressing CX3C chemokine fractalkine (Ad.CMV.FKN). Intratumoral injection of Ad.CMV.FKN strongly suppressed C26 tumor by 65 % and B16 tumor by 82 %. Immunohistochemistry of tumor treated by Ad.CMV.FKN revealed abundant infiltration of NK cells, CD4 T cells, and CD8 T cells. Vaccinations with Ad.CMV.FKN treated B16 cells inhibited tumor growth of wild type B16. These results indicated that CX3C chemokine induced strong anti-tumor immune responses by recruiting NK cells and T lymphocytes.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Iwakami S, Setoguchi Y, Saijo Y, Azuma M, Fukuchi Y.: "Replication-deficient adenovirus-mediated transfer of B7-1 (CD80) cDNA induces anti-tumor immunity in isolated human lung cancer"Respirology. 6. 135-144 (2001)
Iwakami S、Setoguchi Y、Saijo Y、Azuma M、Fukuchi Y.:“复制缺陷型腺病毒介导的 B7-1 (CD80) cDNA 转移在分离的人肺癌中诱导抗肿瘤免疫”呼吸学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiro Usui, Yasuo Saijo, Ko Narumi Shohei Koyama, Makoto Maemondo, Toshiaki Kikuchi, Ryushi Tazawa, Koichi Hagiwara, Yoshitomo Ishibashi, Shigeo Ohta, and Toshihiro Nukiwa.: "N-terminal deletion augments the cell-death inducing activity of BAX in adeno
Kazuhiro Usui、Yasuo Saijo、Ko Narumi Shohei Koyama、Makoto Maemondo、Toshiaki Kikuchi、R​​yushi Tazawa、Koichi Hagiwara、Yoshitomo Ishibashi、Shigeo Ohta 和 Toshihiro Nukiwa。:“N 末端删除增强了腺中 BAX 的细胞死亡诱导活性
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Pradono P, Tazawa R Maemondo M, Saijo Y, et al.: "Gene transfer of thronbokisan (TX) A_2 synthase and prostaglandin (PG) I_2 synthase antithetically altered tumor angiogenesis and tumor growth"Cancer Research. 62. 63-66 (2002)
Pradono P、Tazawa R Maemondo M、Saijo Y 等人:“血栓素 (TX) A_2 合酶和前列腺素 (PG) I_2 合酶的基因转移相反地改变了肿瘤血管生成和肿瘤生长”癌症研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Saijo Y, Tanaka M, Miki M, et al.: "Proinflammatory Cytokine Interleukin-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors"Journal of Immunology. 169. 469-475 (2002)
Saijo Y、Tanaka M、Miki M 等人:“促炎性细胞因子白细胞介素 1β 通过诱导血管生成因子促进路易斯肺癌的肿瘤生长”《免疫学杂志》169. 469-475 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    a study and new treatment of lung cancer stem cells
    • 批准号:
      20390229
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2008
    • 负责人:
      SAIJO Yasuo
    • 依托单位:
    Tumor-Targeting gene therapy and regeneration of injured lung by mssenchymal stem cells
    • 批准号:
      16390232
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2004
    • 负责人:
      SAIJO Yasuo
    • 依托单位:
    Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.
    • 批准号:
      11670563
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      SAIJO Yasuo
    • 依托单位: